menu search

Excision biotherapeutics announces presentation of interim clinical data for ebt-101 in latent hiv at upcoming european society of gene and cell therapy (esgct) 2023 annual congress

SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) — Excision BioTherapeutics, Inc., a clinical-stage biotechnology company developing CRISPR-based thera...

October 19, 2023, 11:50 am

Hookipa pharma announces publication of preclinical data of hepatitis b virus (hbv) therapeutic vaccine developed in collaboration with gilead sciences

HB-400, a novel arenaviral therapeutic vaccine, generates robust T cell responses specific to hepatitis B virus with high antibody levels in a preclin...

October 18, 2023, 11:01 am

Scancell to speak at prestigious vaccine event

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), which is developing immunotherapies for cancer and infectious...

October 18, 2023, 3:14 am

Iterum therapeutics to present data at idweek 2023

DUBLIN, Ireland and CHICAGO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical c...

October 12, 2023, 9:15 am

An2 therapeutics to present new data for epetraborole at idweek 2023

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatment...

October 11, 2023, 12:01 am

Agilent (a) bolsters ntd research with sidc partnership

Agilent (A) collaborates with Sarawak infectious Disease Centre to provide the latter with its 6475 tri...

October 10, 2023, 12:01 pm

Gsk reportedly set to shake up r&d opertion

GSK PLC (LSE:GSK, NYSE:GSK) is set to restructure its research division, impacting scientists in the UK, the US, and Belgium, according to the Sunday ...

October 9, 2023, 2:14 am

Opko health (opk) gets barda contract to combat antibody threats

OPKO Health's (OPK) latest awarded funding is likely to enable the development of novel multispecific antibodies against viral ...

October 6, 2023, 1:32 pm

Modex therapeutics secures barda contract to develop novel multispecific antibodies against viral infectious disease threats

Provides Initial $59 Million and up to $168 Million Contingent on Milestones NATICK, Mass., Sept. 28, 2023 (GLOBE NEWSWIRE) — ModeX Therapeutics Inc...

September 28, 2023, 8:08 pm

Pds biotech reschedules key opinion leader roundtable addressing current and future treatments for recurrent/metastatic hpv-positive hnscc and the potential application of pds0101

Event to be held on Tuesday, October 3 from 8:00 to 9:00 AM EDT PRINCETON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Na...

September 25, 2023, 12:00 pm

Moderna is expecting massive growth over the next decade. is the stock a no-brainer buy?

Moderna is investing in such areas as oncology, rare diseases, and infectious diseases. The biotech pro...

September 22, 2023, 8:45 am

Nvidia and amgen back ai drug developer generate:biomedicines' $273m financing

Generate:Biomedicines said it has raised $273 million to fund its pipeline of programs in preclinical and clinical development across oncology, immuno...

September 14, 2023, 11:29 am

Pharmadrug advances investigational cancer therapeutic pd-001 toward in human safety trials

PharmaDrug Inc (CSE:PHRX, OTCQB:LMLLF) said it continues to advance its patented reformulated enteric-coated version of orally bioavailable cepharanth...

September 14, 2023, 8:56 am

Moderna, inc. (mrna) r&d day and business updates (transcript)

Moderna, Inc. (NASDAQ:MRNA ) R&D Day and Business Updates September 13, 2023 1:00 PM ET Company Participants Stephane Bancel - CEO Stephen Hoge - Pres...

September 14, 2023, 1:29 am

Moderna aims to prove it's ‘more than a covid company'

As it looks to expand its horizons beyond COVID-19 vaccines, Moderna Inc. MRNA, -0.53% on Wednesday released positive results from a late-stage trial ...

September 13, 2023, 6:32 am

Eagle pharmaceuticals to present cal02 trial in progress at the 2023 asm/escmid joint conference on drug development to meet the challenge of antimicrobial resistance

-- CAL02 is a unique therapeutic agent that is designed to work differently from antibiotics, aiming to disarm an ...

September 11, 2023, 6:50 am

Pds biotech to participate at the h.c. wainwright 25th annual global investment conference

PRINCETON, N.J., Sept. 06, 2023 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (PDS Biotech or the Company), a clinical-stage immun...

September 6, 2023, 8:05 pm

60 degrees pharmaceuticals to participate in h.c. wainwright 25th annual global investment conference

Management investor presentation webcast available Monday 9/11, 7:00 AM ET Attendees may request 1 x 1 meetings with management at [email protected] ...

September 6, 2023, 11:31 am

60 degrees pharmaceuticals to participate in h.c. wainwright 25th annual global investment conference

WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals Inc. (“60P” or the “Company”) (Nasdaq: SXTP ), a pharmaceutical comp...

September 6, 2023, 7:31 am

Detergent market size worth usd 176.3 billion by 2031, expanding at a cagr of 4.3% – exclusive report by transparency market research

Increased hygienic awareness among consumers owing to the increased infectious diseases is likely to dr...

September 1, 2023, 10:17 am


Search within

Pages Search Results: